Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Monique Maurer
Institutions:
University of Zurich,
University Hospital Zurich,
University of Bamberg
Observed institutions:
University of Zurich,
University Hospital Zurich,
University of Bamberg
ORCID:
0009-0009-0615-6608
Observed ORCIDs:
0009-0009-0615-6608,
0009-0006-4289-5625
OpenAlex ID:
A5017319937
Efficient combinatorial adaptor-mediated targeting of acute myeloid leukemia with CAR T-cells
2024
·
Laura Volta
, Renier Myburgh
, et al.
·
Leukemia
·
25
PDF
A single‐chain variable fragment‐based bispecific T‐cell activating antibody against CD117 enables T‐cell mediated lysis of acute myeloid leukemia and hematopoietic stem and progenitor cells
2024
·
Laura Volta
, Renier Myburgh
, et al.
·
HemaSphere
·
13
PDF
A Bispecific Anti-Fluorescein × Anti-CD3 T-cell Engager in Combination with Fluoresceinated Adaptors Enables Lysis of AML Cells
2026
·
Laura G. Volta
, Celeste Gobbi
, et al.
·
Molecular Cancer Therapeutics
·
1
PDF
Efficient Combinatorial Adaptor-Mediated Targeting of Acute Myeloid Leukemia with CAR T-Cells
2023
·
Laura Volta
, Renier Myburgh
, et al.
·
Blood
·
1
PDF
Designing an Urban Witch Trial AR Tour and Evaluating Its Knowledge Transfer and User Acceptance
2026
·
Monique Maurer
, Sophie Jörg
·
Lecture notes in computer science
Supplementary Table S2 from A Bispecific Anti-Fluorescein × Anti-CD3 T-cell Engager in Combination with Fluoresceinated Adaptors Enables Lysis of AML Cells
2026
·
Laura G. Volta
, Celeste Gobbi
, et al.
Supplementary Table S1 from A Bispecific Anti-Fluorescein × Anti-CD3 T-cell Engager in Combination with Fluoresceinated Adaptors Enables Lysis of AML Cells
2026
·
Laura G. Volta
, Celeste Gobbi
, et al.
Supplementary Figure S4 from A Bispecific Anti-Fluorescein × Anti-CD3 T-cell Engager in Combination with Fluoresceinated Adaptors Enables Lysis of AML Cells
2026
·
Laura G. Volta
, Celeste Gobbi
, et al.
Supplementary Figure S1 from A Bispecific Anti-Fluorescein × Anti-CD3 T-cell Engager in Combination with Fluoresceinated Adaptors Enables Lysis of AML Cells
2026
·
Laura G. Volta
, Celeste Gobbi
, et al.
Supplementary Figure S5 from A Bispecific Anti-Fluorescein × Anti-CD3 T-cell Engager in Combination with Fluoresceinated Adaptors Enables Lysis of AML Cells
2026
·
Laura G. Volta
, Celeste Gobbi
, et al.
Data from A Bispecific Anti-Fluorescein × Anti-CD3 T-cell Engager in Combination with Fluoresceinated Adaptors Enables Lysis of AML Cells
2026
·
Laura G. Volta
, Celeste Gobbi
, et al.
Supplementary Figure S2 from A Bispecific Anti-Fluorescein × Anti-CD3 T-cell Engager in Combination with Fluoresceinated Adaptors Enables Lysis of AML Cells
2026
·
Laura G. Volta
, Celeste Gobbi
, et al.
Supplementary Figure S3 from A Bispecific Anti-Fluorescein × Anti-CD3 T-cell Engager in Combination with Fluoresceinated Adaptors Enables Lysis of AML Cells
2026
·
Laura G. Volta
, Celeste Gobbi
, et al.
Supplementary Figure S5 from Enhancement of CD117-Targeted Bispecific T-cell Engagement by CD33-Targeted Bispecific T-cell Costimulation in Acute Myeloid Leukemia
2026
·
Mara Hofstetter
, Laura Volta
, et al.
Figure 4 from Enhancement of CD117-Targeted Bispecific T-cell Engagement by CD33-Targeted Bispecific T-cell Costimulation in Acute Myeloid Leukemia
2026
·
Mara Hofstetter
, Laura Volta
, et al.
Supplementary Figure S3 from Enhancement of CD117-Targeted Bispecific T-cell Engagement by CD33-Targeted Bispecific T-cell Costimulation in Acute Myeloid Leukemia
2026
·
Mara Hofstetter
, Laura Volta
, et al.
Figure 5 from Enhancement of CD117-Targeted Bispecific T-cell Engagement by CD33-Targeted Bispecific T-cell Costimulation in Acute Myeloid Leukemia
2026
·
Mara Hofstetter
, Laura Volta
, et al.
Supplementary Figure S2 from Enhancement of CD117-Targeted Bispecific T-cell Engagement by CD33-Targeted Bispecific T-cell Costimulation in Acute Myeloid Leukemia
2026
·
Mara Hofstetter
, Laura Volta
, et al.
Figure 2 from Enhancement of CD117-Targeted Bispecific T-cell Engagement by CD33-Targeted Bispecific T-cell Costimulation in Acute Myeloid Leukemia
2026
·
Mara Hofstetter
, Laura Volta
, et al.
Supplementary Table S1 from Enhancement of CD117-Targeted Bispecific T-cell Engagement by CD33-Targeted Bispecific T-cell Costimulation in Acute Myeloid Leukemia
2026
·
Mara Hofstetter
, Laura Volta
, et al.
Supplementary Figure S6 from Enhancement of CD117-Targeted Bispecific T-cell Engagement by CD33-Targeted Bispecific T-cell Costimulation in Acute Myeloid Leukemia
2026
·
Mara Hofstetter
, Laura Volta
, et al.
Supplementary Figure S4 from Enhancement of CD117-Targeted Bispecific T-cell Engagement by CD33-Targeted Bispecific T-cell Costimulation in Acute Myeloid Leukemia
2026
·
Mara Hofstetter
, Laura Volta
, et al.
Figure 3 from Enhancement of CD117-Targeted Bispecific T-cell Engagement by CD33-Targeted Bispecific T-cell Costimulation in Acute Myeloid Leukemia
2026
·
Mara Hofstetter
, Laura Volta
, et al.
Supplementary Figure S1 from Enhancement of CD117-Targeted Bispecific T-cell Engagement by CD33-Targeted Bispecific T-cell Costimulation in Acute Myeloid Leukemia
2026
·
Mara Hofstetter
, Laura Volta
, et al.
Data from Enhancement of CD117-Targeted Bispecific T-cell Engagement by CD33-Targeted Bispecific T-cell Costimulation in Acute Myeloid Leukemia
2026
·
Mara Hofstetter
, Laura Volta
, et al.
Show more works
View as search
Works count:
30
Citation count:
40
H-index:
2
I10-index:
2
Year
Topic
Type